• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Wylie, James P
    Cowan, Richard A
    Radford, John A
    Deakin, David P
    Harris, Maggie A
    Wilkinson, Peter M
    Affiliation
    Department of Clinical Oncology, Christie Hospital NHS Trust, Manchester, UK.
    Issue Date
    2000
    
    Metadata
    Show full item record
    Abstract
    A retrospective analysis was performed on 66 patients, aged 70 years or older, who received treatment with a weekly doxorubicin-containing regimen (VAPEC-B) for high grade non-Hodgkin's lymphoma (NHL). Two dosing schedules were employed. The choice of regimen was at the discretion of the treating clinician and reflected the performance status of the patient and the predicted tolerance to chemotherapy. Forty-nine patients received a half-dose schedule and 17 the full-dose schedule. Those receiving the half-dose regimen had a lower median performance status and received a lower dose intensity of chemotherapy (45% versus 83%). However, the outcomes of the two groups were similar: complete remission rate 41% versus 47%, and 5-year overall survival 36% versus 23%, for the half- and full-dose groups, respectively. A similar proportion of patients (51% versus 59%) completed each regimen, although there were more delays in treatment delivery experienced in those receiving the full dose. Half-dose VAPEC-B is an effective treatment option for elderly patients with high-grade NHL and has comparable efficacy with other published regimens. The use of such low-dose doxorubicin-containing regimens in elderly patients with high-grade NHL requires further investigation.
    Citation
    A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma. 2000, 12 (3):153-7 Clin Oncol
    Journal
    Clinical Oncology
    URI
    http://hdl.handle.net/10541/85440
    DOI
    10.1053/clon.2000.9142
    PubMed ID
    10942331
    Type
    Article
    Language
    en
    ISSN
    0936-6555
    ae974a485f413a2113503eed53cd6c53
    10.1053/clon.2000.9142
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients.
    • Authors: Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR, Lakhani A, Mufti GJ
    • Issue date: 1995
    • Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    • Authors: Sweetenham JW, Mead GM, Whitehouse JM
    • Issue date: 1991 Dec
    • Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patients.
    • Authors: Radford JA, Whelan JS, Rohatiner AZ, Deakin D, Harris M, Stansfeld AG, Swindell R, Wilkinson PM, James RD, Lister TA
    • Issue date: 1994 Feb
    • CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
    • Authors: Cameron DA, White JM, Proctor SJ, Prescott RJ, Leonard RC, Angus B, Cook MK, Dawes PJ, Dawson AA, Evans RG, Galloway MJ, Harris AL, Heppleston A, Horne CH, Krajewski AS, Lennard AL, Lessells AM, Lucraft HH, MacGillivray JB, Mackie MJ, Parker AC, Roberts JT, Taylor PR, Thompson WD
    • Issue date: 1997 Jul
    • The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
    • Authors: Shpilberg O, Shiff J, Chetrit A, Ramot B, Ben-Bassat I
    • Issue date: 1994 Dec 1
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.